Dextran 75

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Dextran 75
Accession Number
DB11241
Type
Small Molecule
Groups
Approved
Description

Dextran 75 is a complex branched glucan with an average molecular weight 75000 Daltons. It is produced from certain bacteria that with α-1,6 glycosidic linkages between glucose molecules and α-1,3 linkages between branches. Dextrans are used therapeutically as plasma volume expanders in hypovolemia and antithrombin agents to reduce blood viscosity. When labelled with technetium Tc99m, dextran 75 is intravenously administered as an imaging agent to detect and diagnose conditions in the vascular compartment such as pericardial effusion or ventricular aneurysm.

Synonyms
Not Available
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Dextran 75Dextran 75 (10 mg/1)Injection, powder, lyophilized, for solutionIntravenousAnazao Health Corporation2012-07-01Not applicableUs
Categories
UNII
JY83SHX053
CAS number
Not Available
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
(4R)-limonene(4R)-limonene may increase the anticoagulant activities of Dextran 75.Investigational
AbciximabAbciximab may increase the anticoagulant activities of Dextran 75.Approved
AceclofenacAceclofenac may increase the anticoagulant activities of Dextran 75.Approved, Investigational
AcemetacinThe risk or severity of bleeding can be increased when Dextran 75 is combined with Acemetacin.Approved, Experimental, Investigational
AcenocoumarolAcenocoumarol may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Acetylsalicylic acidAcetylsalicylic acid may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
AdapaleneAdapalene may increase the anticoagulant activities of Dextran 75.Approved
AlclofenacAlclofenac may increase the anticoagulant activities of Dextran 75.Approved, Withdrawn
AllylestrenolThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Allylestrenol.Approved
AlminoprofenAlminoprofen may increase the anticoagulant activities of Dextran 75.Experimental
AloxiprinAloxiprin may increase the anticoagulant activities of Dextran 75.Experimental
AlprostadilAlprostadil may increase the anticoagulant activities of Dextran 75.Approved, Investigational
AlteplaseAlteplase may increase the anticoagulant activities of Dextran 75.Approved
AltrenogestThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Altrenogest.Vet Approved
Aminosalicylic AcidAminosalicylic Acid may increase the anticoagulant activities of Dextran 75.Approved
AnagrelideAnagrelide may increase the anticoagulant activities of Dextran 75.Approved
AncrodAncrod may increase the anticoagulant activities of Dextran 75.Approved, Investigational
AndrographolideAndrographolide may increase the anticoagulant activities of Dextran 75.Investigational
AnisodamineAnisodamine may increase the anticoagulant activities of Dextran 75.Investigational
AnistreplaseAnistreplase may increase the anticoagulant activities of Dextran 75.Approved
AntipyrineAntipyrine may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Antithrombin III humanDextran 75 may increase the anticoagulant activities of Antithrombin III human.Approved
ApixabanApixaban may increase the anticoagulant activities of Dextran 75.Approved
ApocyninApocynin may increase the anticoagulant activities of Dextran 75.Investigational
ApremilastApremilast may increase the anticoagulant activities of Dextran 75.Approved, Investigational
ArdeparinArdeparin may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
ArgatrobanArgatroban may increase the anticoagulant activities of Dextran 75.Approved, Investigational
AstaxanthinAstaxanthin may increase the anticoagulant activities of Dextran 75.Investigational
AzapropazoneAzapropazone may increase the anticoagulant activities of Dextran 75.Withdrawn
AzelastineAzelastine may increase the anticoagulant activities of Dextran 75.Approved
BalsalazideBalsalazide may increase the anticoagulant activities of Dextran 75.Approved, Investigational
BatroxobinBatroxobin may increase the anticoagulant activities of Dextran 75.Experimental
BecaplerminBecaplermin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
BemiparinBemiparin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
BendazacBendazac may increase the anticoagulant activities of Dextran 75.Experimental
BenorilateBenorilate may increase the anticoagulant activities of Dextran 75.Experimental
BenoxaprofenBenoxaprofen may increase the anticoagulant activities of Dextran 75.Withdrawn
BenzydamineBenzydamine may increase the anticoagulant activities of Dextran 75.Approved
BeraprostBeraprost may increase the anticoagulant activities of Dextran 75.Investigational
BevoniumBevonium may increase the anticoagulant activities of Dextran 75.Experimental
BivalirudinBivalirudin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
BrinaseBrinase may increase the anticoagulant activities of Dextran 75.Experimental
BromfenacBromfenac may increase the anticoagulant activities of Dextran 75.Approved
BucillamineBucillamine may increase the anticoagulant activities of Dextran 75.Investigational
BufexamacBufexamac may increase the anticoagulant activities of Dextran 75.Approved, Experimental
BuflomedilBuflomedil may increase the anticoagulant activities of Dextran 75.Experimental
BumadizoneBumadizone may increase the anticoagulant activities of Dextran 75.Experimental
ButylphthalideButylphthalide may increase the anticoagulant activities of Dextran 75.Investigational
CangrelorCangrelor may increase the anticoagulant activities of Dextran 75.Approved
CaplacizumabCaplacizumab may increase the anticoagulant activities of Dextran 75.Investigational
Carbaspirin calciumCarbaspirin calcium may increase the anticoagulant activities of Dextran 75.Experimental, Investigational
CarprofenCarprofen may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved, Withdrawn
CastanospermineCastanospermine may increase the anticoagulant activities of Dextran 75.Experimental
CelecoxibCelecoxib may increase the anticoagulant activities of Dextran 75.Approved, Investigational
CertoparinCertoparin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
ChloroquineChloroquine may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
ChlorotrianiseneChlorotrianisene may decrease the anticoagulant activities of Dextran 75.Investigational, Withdrawn
Choline magnesium trisalicylateCholine magnesium trisalicylate may increase the anticoagulant activities of Dextran 75.Approved
CilostazolCilostazol may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Citric AcidCitric Acid may increase the anticoagulant activities of Dextran 75.Approved, Nutraceutical, Vet Approved
ClonixinClonixin may increase the anticoagulant activities of Dextran 75.Approved
ClopidogrelClopidogrel may increase the anticoagulant activities of Dextran 75.Approved
CloricromenCloricromen may increase the anticoagulant activities of Dextran 75.Experimental
ClorindioneClorindione may increase the anticoagulant activities of Dextran 75.Experimental
Collagenase clostridium histolyticumThe risk or severity of adverse effects can be increased when Dextran 75 is combined with Collagenase clostridium histolyticum.Approved, Investigational
Conjugated estrogensConjugated estrogens may decrease the anticoagulant activities of Dextran 75.Approved
CurcuminCurcumin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Dabigatran etexilateDabigatran etexilate may increase the anticoagulant activities of Dextran 75.Approved
DaidzeinDaidzein may decrease the anticoagulant activities of Dextran 75.Experimental
DalteparinDalteparin may increase the anticoagulant activities of Dextran 75.Approved
DanaparoidDanaparoid may increase the anticoagulant activities of Dextran 75.Approved, Withdrawn
DarexabanDextran 75 may increase the anticoagulant activities of Darexaban.Investigational
DasatinibDasatinib may increase the anticoagulant activities of Dextran 75.Approved, Investigational
DeferasiroxThe risk or severity of adverse effects can be increased when Dextran 75 is combined with Deferasirox.Approved, Investigational
DefibrotideDefibrotide may increase the anticoagulant activities of Dextran 75.Approved, Investigational
DemegestoneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Demegestone.Experimental
Deoxycholic AcidThe risk or severity of adverse effects can be increased when Dextran 75 is combined with Deoxycholic Acid.Approved
DersalazineDersalazine may increase the anticoagulant activities of Dextran 75.Investigational
DesirudinDesirudin may increase the anticoagulant activities of Dextran 75.Approved
DesmoteplaseDesmoteplase may increase the anticoagulant activities of Dextran 75.Investigational
DesogestrelThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Desogestrel.Approved
DextranDextran may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
Dextran 40Dextran 40 may increase the anticoagulant activities of Dextran 75.Approved
Dextran 70Dextran 70 may increase the anticoagulant activities of Dextran 75.Approved
DiclofenacDiclofenac may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
DicoumarolDicoumarol may increase the anticoagulant activities of Dextran 75.Approved
DienestrolDienestrol may decrease the anticoagulant activities of Dextran 75.Approved, Investigational
DienogestThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Dienogest.Approved
DiethylstilbestrolDiethylstilbestrol may decrease the anticoagulant activities of Dextran 75.Approved, Investigational
DifenpiramideDifenpiramide may increase the anticoagulant activities of Dextran 75.Experimental
DiflunisalDiflunisal may increase the anticoagulant activities of Dextran 75.Approved, Investigational
DiphenadioneDiphenadione may increase the anticoagulant activities of Dextran 75.Experimental
DipyridamoleDipyridamole may increase the anticoagulant activities of Dextran 75.Approved
DitazoleDitazole may increase the anticoagulant activities of Dextran 75.Approved, Withdrawn
Drotrecogin alfaDrotrecogin alfa may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
DroxicamDroxicam may increase the anticoagulant activities of Dextran 75.Withdrawn
DuvelisibDuvelisib may increase the anticoagulant activities of Dextran 75.Investigational
DydrogesteroneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Dydrogesterone.Approved, Investigational, Withdrawn
E-6201E-6201 may increase the anticoagulant activities of Dextran 75.Investigational
Edetic AcidEdetic Acid may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
EdoxabanEdoxaban may increase the anticoagulant activities of Dextran 75.Approved
EnoxaparinEnoxaparin may increase the anticoagulant activities of Dextran 75.Approved
EpimestrolEpimestrol may decrease the anticoagulant activities of Dextran 75.Experimental
EpinastineEpinastine may increase the anticoagulant activities of Dextran 75.Approved, Investigational
EpirizoleEpirizole may increase the anticoagulant activities of Dextran 75.Approved
EplivanserinEplivanserin may increase the anticoagulant activities of Dextran 75.Investigational
eplivanserineeplivanserine may increase the anticoagulant activities of Dextran 75.Investigational
EpoprostenolEpoprostenol may increase the anticoagulant activities of Dextran 75.Approved
EptifibatideEptifibatide may increase the anticoagulant activities of Dextran 75.Approved, Investigational
EquolEquol may decrease the anticoagulant activities of Dextran 75.Investigational
EstradiolEstradiol may decrease the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
Estradiol acetateEstradiol acetate may decrease the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
Estradiol cypionateEstradiol cypionate may decrease the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
Estradiol valerateEstradiol valerate may decrease the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
EstriolEstriol may decrease the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
Estrogens, esterifiedEstrogens, esterified may decrease the anticoagulant activities of Dextran 75.Approved
EstroneEstrone may decrease the anticoagulant activities of Dextran 75.Approved
EtanerceptEtanercept may increase the anticoagulant activities of Dextran 75.Approved, Investigational
EthenzamideEthenzamide may increase the anticoagulant activities of Dextran 75.Experimental
Ethinyl EstradiolEthinyl Estradiol may decrease the anticoagulant activities of Dextran 75.Approved
Ethyl biscoumacetateEthyl biscoumacetate may increase the anticoagulant activities of Dextran 75.Withdrawn
EtodolacEtodolac may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
EtofenamateEtofenamate may increase the anticoagulant activities of Dextran 75.Approved, Investigational
EtonogestrelThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Etonogestrel.Approved, Investigational
EtoricoxibEtoricoxib may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Evening primrose oilEvening primrose oil may increase the anticoagulant activities of Dextran 75.Approved, Investigational
ExisulindExisulind may increase the anticoagulant activities of Dextran 75.Investigational
FelbinacFelbinac may increase the anticoagulant activities of Dextran 75.Experimental
FenbufenFenbufen may increase the anticoagulant activities of Dextran 75.Approved
FenoprofenFenoprofen may increase the anticoagulant activities of Dextran 75.Approved
FentiazacFentiazac may increase the anticoagulant activities of Dextran 75.Experimental
FeprazoneFeprazone may increase the anticoagulant activities of Dextran 75.Experimental
Ferulic acidFerulic acid may increase the anticoagulant activities of Dextran 75.Experimental
FibrinolysinFibrinolysin may increase the anticoagulant activities of Dextran 75.Investigational
FloctafenineFloctafenine may increase the anticoagulant activities of Dextran 75.Approved, Withdrawn
FluindioneDextran 75 may increase the anticoagulant activities of Fluindione.Approved, Investigational
FlunixinFlunixin may increase the anticoagulant activities of Dextran 75.Vet Approved
FlunoxaprofenFlunoxaprofen may increase the anticoagulant activities of Dextran 75.Experimental
FlurbiprofenFlurbiprofen may increase the anticoagulant activities of Dextran 75.Approved, Investigational
FondaparinuxDextran 75 may increase the anticoagulant activities of Fondaparinux.Approved, Investigational
Fondaparinux sodiumFondaparinux sodium may increase the anticoagulant activities of Dextran 75.Approved, Investigational
GabexateDextran 75 may increase the anticoagulant activities of Gabexate.Investigational
GenisteinGenistein may decrease the anticoagulant activities of Dextran 75.Investigational
GestodeneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Gestodene.Approved, Investigational
GestonoroneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Gestonorone.Experimental
GestrinoneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Gestrinone.Approved
GuacetisalGuacetisal may increase the anticoagulant activities of Dextran 75.Experimental
HeminHemin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Hemoglobin crosfumarilHemoglobin crosfumaril may increase the anticoagulant activities of Dextran 75.Experimental
HeparinHeparin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
HexestrolHexestrol may decrease the anticoagulant activities of Dextran 75.Withdrawn
HigenamineHigenamine may increase the anticoagulant activities of Dextran 75.Investigational
Hydroxyprogesterone caproateThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Hydroxyprogesterone caproate.Approved, Investigational
HydroxytyrosolHydroxytyrosol may increase the anticoagulant activities of Dextran 75.Investigational
Ibritumomab tiuxetanThe risk or severity of adverse effects can be increased when Dextran 75 is combined with Ibritumomab tiuxetan.Approved, Investigational
IbrutinibThe risk or severity of adverse effects can be increased when Ibrutinib is combined with Dextran 75.Approved
IbudilastIbudilast may increase the anticoagulant activities of Dextran 75.Approved, Investigational
IbuprofenIbuprofen may increase the anticoagulant activities of Dextran 75.Approved
IbuproxamIbuproxam may increase the anticoagulant activities of Dextran 75.Withdrawn
IcatibantIcatibant may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Icosapent ethylIcosapent ethyl may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Nutraceutical
IdraparinuxIdraparinux may increase the anticoagulant activities of Dextran 75.Investigational
IfenprodilIfenprodil may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
IfetrobanIfetroban may increase the anticoagulant activities of Dextran 75.Investigational
IloprostIloprost may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Imidazole salicylateImidazole salicylate may increase the anticoagulant activities of Dextran 75.Experimental
IndobufenIndobufen may increase the anticoagulant activities of Dextran 75.Investigational
IndomethacinIndomethacin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
IndoprofenIndoprofen may increase the anticoagulant activities of Dextran 75.Withdrawn
IsoxicamIsoxicam may increase the anticoagulant activities of Dextran 75.Withdrawn
KebuzoneKebuzone may increase the anticoagulant activities of Dextran 75.Experimental
KetanserinKetanserin may increase the anticoagulant activities of Dextran 75.Investigational
KetoprofenKetoprofen may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
KetorolacKetorolac may increase the anticoagulant activities of Dextran 75.Approved
LeflunomideLeflunomide may increase the anticoagulant activities of Dextran 75.Approved, Investigational
LepirudinLepirudin may increase the anticoagulant activities of Dextran 75.Approved
LetaxabanDextran 75 may increase the anticoagulant activities of Letaxaban.Investigational
LevonorgestrelThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Levonorgestrel.Approved, Investigational
LimaprostThe risk or severity of adverse effects can be increased when Limaprost is combined with Dextran 75.Approved, Investigational
LinsidomineLinsidomine may increase the anticoagulant activities of Dextran 75.Experimental
LisofyllineLisofylline may increase the anticoagulant activities of Dextran 75.Investigational
LonazolacLonazolac may increase the anticoagulant activities of Dextran 75.Experimental
LornoxicamLornoxicam may increase the anticoagulant activities of Dextran 75.Approved, Investigational
LoxoprofenLoxoprofen may increase the anticoagulant activities of Dextran 75.Approved, Investigational
LumiracoxibLumiracoxib may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Magnesium salicylateMagnesium salicylate may increase the anticoagulant activities of Dextran 75.Approved
MasoprocolMasoprocol may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Meclofenamic acidMeclofenamic acid may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
MedrogestoneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Medrogestone.Approved
Medroxyprogesterone acetateThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Medroxyprogesterone acetate.Approved, Investigational
Mefenamic acidMefenamic acid may increase the anticoagulant activities of Dextran 75.Approved
Megestrol acetateThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Megestrol acetate.Approved, Investigational, Vet Approved
MelagatranDextran 75 may increase the anticoagulant activities of Melagatran.Experimental
MeloxicamMeloxicam may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
MesalazineMesalazine may increase the anticoagulant activities of Dextran 75.Approved
MestranolMestranol may decrease the anticoagulant activities of Dextran 75.Approved
MetamizoleMetamizole may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
MethallenestrilMethallenestril may decrease the anticoagulant activities of Dextran 75.Experimental
Methyl salicylateMethyl salicylate may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
MethylestrenoloneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Methylestrenolone.Experimental
MilrinoneMilrinone may increase the anticoagulant activities of Dextran 75.Approved
MizoribineMizoribine may increase the anticoagulant activities of Dextran 75.Investigational
MofebutazoneMofebutazone may increase the anticoagulant activities of Dextran 75.Experimental
MoxestrolMoxestrol may decrease the anticoagulant activities of Dextran 75.Experimental
Mycophenolate mofetilMycophenolate mofetil may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Mycophenolic acidMycophenolic acid may increase the anticoagulant activities of Dextran 75.Approved
NabumetoneNabumetone may increase the anticoagulant activities of Dextran 75.Approved
NadroparinNadroparin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
NafamostatNafamostat may increase the anticoagulant activities of Dextran 75.Approved, Investigational
NaftifineNaftifine may increase the anticoagulant activities of Dextran 75.Approved
NaftopidilNaftopidil may increase the anticoagulant activities of Dextran 75.Investigational
NaproxenNaproxen may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
NepafenacNepafenac may increase the anticoagulant activities of Dextran 75.Approved, Investigational
NifenazoneNifenazone may increase the anticoagulant activities of Dextran 75.Experimental
Niflumic AcidNiflumic Acid may increase the anticoagulant activities of Dextran 75.Approved
NimesulideNimesulide may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
NintedanibThe risk or severity of adverse effects can be increased when Dextran 75 is combined with Nintedanib.Approved
NitroaspirinNitroaspirin may increase the anticoagulant activities of Dextran 75.Investigational
NomegestrolThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Nomegestrol.Approved
NorethisteroneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Norethisterone.Approved
NorgestrienoneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Norgestrienone.Experimental
ObinutuzumabThe risk or severity of adverse effects can be increased when Dextran 75 is combined with Obinutuzumab.Approved, Investigational
OlopatadineOlopatadine may increase the anticoagulant activities of Dextran 75.Approved
OlsalazineOlsalazine may increase the anticoagulant activities of Dextran 75.Approved
Omacetaxine mepesuccinateThe risk or severity of bleeding can be increased when Dextran 75 is combined with Omacetaxine mepesuccinate.Approved, Investigational
Omega-3 fatty acidsOmega-3 fatty acids may increase the anticoagulant activities of Dextran 75.Approved, Nutraceutical
OrgoteinOrgotein may increase the anticoagulant activities of Dextran 75.Vet Approved
OtamixabanOtamixaban may increase the anticoagulant activities of Dextran 75.Investigational
OxaprozinOxaprozin may increase the anticoagulant activities of Dextran 75.Approved
OxyphenbutazoneOxyphenbutazone may increase the anticoagulant activities of Dextran 75.Approved, Withdrawn
OzagrelOzagrel may increase the anticoagulant activities of Dextran 75.Investigational
ParecoxibParecoxib may increase the anticoagulant activities of Dextran 75.Approved
ParnaparinParnaparin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
ParthenolideParthenolide may increase the anticoagulant activities of Dextran 75.Approved, Investigational
Pentaerythritol TetranitratePentaerythritol Tetranitrate may increase the anticoagulant activities of Dextran 75.Approved
Pentosan PolysulfatePentosan Polysulfate may increase the anticoagulant activities of Dextran 75.Approved
PentoxifyllinePentoxifylline may increase the anticoagulant activities of Dextran 75.Approved, Investigational
PhenindionePhenindione may increase the anticoagulant activities of Dextran 75.Approved, Investigational
PhenprocoumonPhenprocoumon may increase the anticoagulant activities of Dextran 75.Approved, Investigational
PhenylbutazonePhenylbutazone may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
PicotamidePicotamide may increase the anticoagulant activities of Dextran 75.Experimental
PimecrolimusPimecrolimus may increase the anticoagulant activities of Dextran 75.Approved, Investigational
PirfenidonePirfenidone may increase the anticoagulant activities of Dextran 75.Approved, Investigational
PiroxicamPiroxicam may increase the anticoagulant activities of Dextran 75.Approved, Investigational
PirprofenPirprofen may increase the anticoagulant activities of Dextran 75.Experimental
Polyestradiol phosphatePolyestradiol phosphate may decrease the anticoagulant activities of Dextran 75.Approved
PranoprofenPranoprofen may increase the anticoagulant activities of Dextran 75.Experimental, Investigational
PrasugrelPrasugrel may increase the anticoagulant activities of Dextran 75.Approved
ProgesteroneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Progesterone.Approved, Vet Approved
ProglumetacinProglumetacin may increase the anticoagulant activities of Dextran 75.Experimental
PromegestoneThe therapeutic efficacy of Dextran 75 can be decreased when used in combination with Promegestone.Experimental
PromestrienePromestriene may decrease the anticoagulant activities of Dextran 75.Investigational
PropacetamolPropacetamol may increase the anticoagulant activities of Dextran 75.Approved, Investigational
PropyphenazonePropyphenazone may increase the anticoagulant activities of Dextran 75.Experimental
ProquazoneProquazone may increase the anticoagulant activities of Dextran 75.Experimental
Protein CDextran 75 may increase the anticoagulant activities of Protein C.Approved
Protein S humanDextran 75 may increase the anticoagulant activities of Protein S human.Approved
ProtocatechualdehydeDextran 75 may increase the anticoagulant activities of Protocatechualdehyde.Approved
PTC299PTC299 may increase the anticoagulant activities of Dextran 75.Investigational
QuinestrolQuinestrol may decrease the anticoagulant activities of Dextran 75.Approved
RamatrobanRamatroban may increase the anticoagulant activities of Dextran 75.Investigational
RelcovaptanRelcovaptan may increase the anticoagulant activities of Dextran 75.Investigational
ResveratrolResveratrol may increase the anticoagulant activities of Dextran 75.Approved, Experimental, Investigational
ReteplaseReteplase may increase the anticoagulant activities of Dextran 75.Approved, Investigational
ReviparinReviparin may increase the anticoagulant activities of Dextran 75.Approved, Investigational
RidogrelRidogrel may increase the anticoagulant activities of Dextran 75.Approved
RivaroxabanDextran 75 may increase the anticoagulant activities of Rivaroxaban.Approved
RofecoxibRofecoxib may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
RosiglitazoneRosiglitazone may increase the anticoagulant activities of Dextran 75.Approved, Investigational
SalicylamideSalicylamide may increase the anticoagulant activities of Dextran 75.Approved
Salicylic acidSalicylic acid may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Vet Approved
SalsalateSalsalate may increase the anticoagulant activities of Dextran 75.Approved
SarpogrelateSarpogrelate may increase the anticoagulant activities of Dextran 75.Investigational
SaruplaseSaruplase may increase the anticoagulant activities of Dextran 75.Experimental
SecoisolariciresinolSecoisolariciresinol may decrease the anticoagulant activities of Dextran 75.Investigational
SelexipagSelexipag may increase the anticoagulant activities of Dextran 75.Approved
SemapimodSemapimod may increase the anticoagulant activities of Dextran 75.Investigational
SeratrodastSeratrodast may increase the anticoagulant activities of Dextran 75.Approved
SerrapeptaseSerrapeptase may increase the anticoagulant activities of Dextran 75.Investigational
SevofluraneSevoflurane may increase the anticoagulant activities of Dextran 75.Approved, Vet Approved
SRT501SRT501 may increase the anticoagulant activities of Dextran 75.Investigational
StreptokinaseStreptokinase may increase the anticoagulant activities of Dextran 75.Approved, Investigational
SugammadexSugammadex may increase the anticoagulant activities of Dextran 75.Approved
SulfasalazineSulfasalazine may increase the anticoagulant activities of Dextran 75.Approved
SulindacSulindac may increase the anticoagulant activities of Dextran 75.Approved, Investigational
SulodexideSulodexide may increase the anticoagulant activities of Dextran 75.Approved, Investigational
SuprofenSuprofen may increase the anticoagulant activities of Dextran 75.Approved, Withdrawn
SuxibuzoneSuxibuzone may increase the anticoagulant activities of Dextran 75.Experimental
Synthetic Conjugated Estrogens, ASynthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Dextran 75.Approved
Synthetic Conjugated Estrogens, BSynthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Dextran 75.Approved
TarenflurbilTarenflurbil may increase the anticoagulant activities of Dextran 75.Investigational
TenecteplaseTenecteplase may increase the anticoagulant activities of Dextran 75.Approved
TenidapTenidap may increase the anticoagulant activities of Dextran 75.Experimental
TenoxicamTenoxicam may increase the anticoagulant activities of Dextran 75.Approved
TepoxalinTepoxalin may increase the anticoagulant activities of Dextran 75.Vet Approved
TeriflunomideTeriflunomide may increase the anticoagulant activities of Dextran 75.Approved
TesmilifeneTesmilifene may increase the anticoagulant activities of Dextran 75.Investigational
Testosterone cypionateThe therapeutic efficacy of Dextran 75 can be increased when used in combination with Testosterone cypionate.Approved
Testosterone enanthateThe therapeutic efficacy of Dextran 75 can be increased when used in combination with Testosterone enanthate.Approved
Testosterone undecanoateThe therapeutic efficacy of Dextran 75 can be increased when used in combination with Testosterone undecanoate.Approved, Investigational
Tiaprofenic acidTiaprofenic acid may increase the anticoagulant activities of Dextran 75.Approved
TiboloneTibolone may increase the anticoagulant activities of Dextran 75.Approved, Investigational
TicagrelorTicagrelor may increase the anticoagulant activities of Dextran 75.Approved
TiclopidineTiclopidine may increase the anticoagulant activities of Dextran 75.Approved
TinoridineTinoridine may increase the anticoagulant activities of Dextran 75.Investigational
TinzaparinTinzaparin may increase the anticoagulant activities of Dextran 75.Approved
TioclomarolTioclomarol may increase the anticoagulant activities of Dextran 75.Experimental
TipranavirTipranavir may increase the anticoagulant activities of Dextran 75.Approved, Investigational
TirofibanTirofiban may increase the anticoagulant activities of Dextran 75.Approved
Tolfenamic AcidTolfenamic Acid may increase the anticoagulant activities of Dextran 75.Approved, Investigational
TolmetinTolmetin may increase the anticoagulant activities of Dextran 75.Approved
TositumomabThe risk or severity of adverse effects can be increased when Dextran 75 is combined with Tositumomab.Approved, Investigational
TranilastTranilast may increase the anticoagulant activities of Dextran 75.Approved, Investigational
TrapidilTrapidil may increase the anticoagulant activities of Dextran 75.Approved
TreprostinilTreprostinil may increase the anticoagulant activities of Dextran 75.Approved, Investigational
TribenosideTribenoside may increase the anticoagulant activities of Dextran 75.Experimental
TriflusalTriflusal may increase the anticoagulant activities of Dextran 75.Approved, Investigational
TriptolideTriptolide may increase the anticoagulant activities of Dextran 75.Investigational
Trolamine salicylateTrolamine salicylate may increase the anticoagulant activities of Dextran 75.Approved
TroxerutinDextran 75 may increase the anticoagulant activities of Troxerutin.Investigational
UrokinaseUrokinase may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
ValdecoxibValdecoxib may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
Vitamin EVitamin E may increase the anticoagulant activities of Dextran 75.Approved, Nutraceutical, Vet Approved
VorapaxarThe risk or severity of adverse effects can be increased when Vorapaxar is combined with Dextran 75.Approved
WarfarinWarfarin may increase the anticoagulant activities of Dextran 75.Approved
XimelagatranXimelagatran may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
ZaltoprofenZaltoprofen may increase the anticoagulant activities of Dextran 75.Approved, Investigational
ZeranolZeranol may decrease the anticoagulant activities of Dextran 75.Vet Approved
ZileutonZileuton may increase the anticoagulant activities of Dextran 75.Approved, Investigational, Withdrawn
ZomepiracZomepirac may increase the anticoagulant activities of Dextran 75.Withdrawn
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911162

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, powder, lyophilized, for solutionIntravenous10 mg/1
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on December 03, 2015 09:51 / Updated on February 03, 2018 16:34